Patents by Inventor Thomas Johannes Maria Beenakker

Thomas Johannes Maria Beenakker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230296569
    Abstract: The disclosed invention is in the field of analytical chemistry. In particular, it relates to methods for improved quantification of analytes in complex mixtures, and to compositions comprising precise amounts of said analytes. The improved method uses stable reference standards.
    Type: Application
    Filed: January 10, 2023
    Publication date: September 21, 2023
    Applicant: ISA Pharmaceuticals B.V.
    Inventors: Brigitte Elisa Anna Burm, Thomas Johannes Maria Beenakker
  • Publication number: 20230242590
    Abstract: The invention provides novel immunogenic peptides derived from the X protein and polymerase protein of hepatitis B virus (HBV). The peptides contain epitopes that are well-conserved across multiple HBV variants and are derived from regions of proteins that are essential for viral replication. Moreover, the novel HBV antigens bind multiple HLA types and epitopes that elicit IFN? responses in PBMCs from HBV resolvers have been identified.
    Type: Application
    Filed: December 4, 2020
    Publication date: August 3, 2023
    Applicants: ISA Pharmaceuticals B.V., Erasmus University Medical Center Rotterdam
    Inventors: Sonja Ingrid Buschow, Monica Theodora Antonetta de Beijer, Miranda Bernardina Johanna Molenaar, Thomas Johannes Maria Beenakker, Wilhelmus Johannes Theodorus Alexander Krebber, Cornelis Johannes Maria Melief, Anna-Sophia Wiekmeijer, Peter van Rijn, Diahann Talia Satirah Ludovica Jansen, Wilhelmus Johannes Elisabeth van Esch
  • Publication number: 20230143215
    Abstract: The invention provides long immunogenic peptides for treating diseases related to severe acute respiratory syndrome coronaviruses, such as SARS-CoV-2 or SARS-CoV-1. The invention also provides immunogenic compositions and vaccines comprises long immunogenic peptides of the invention and method of therapeutic treatment or prevention of SARS-CoV-related diseases comprising administration of immunogenic peptides according to the invention.
    Type: Application
    Filed: April 23, 2021
    Publication date: May 11, 2023
    Applicant: ISA Pharmaceuticals B.V.
    Inventors: Cornelis Johannes Maria Melief, Thomas Johannes Maria Beenakker, Peter van Rijn, Anna-Sophia Wiekmeijer, Miranda Bernardina Johanna Molenaar, Leonard Willem Frederik Hooftman
  • Publication number: 20230087422
    Abstract: The invention provides methods for treating infections, disorders or diseases caused by a human papillomavirus other than HPV-16 by determining the HPV type of the patient, providing a synthetic-long-peptide based therapeutic vaccine for treatment of said patient and administering said therapeutic vaccine to said patient. The invention further provides novel immunogenic compositions and therapeutic vaccines against human papillomaviruses other than HPV-16 and uses thereof.
    Type: Application
    Filed: February 5, 2021
    Publication date: March 23, 2023
    Applicant: ISA Pharmaceuticals B.V.
    Inventors: Thomas Johannes Maria Beenakker, Gerben Moolhuizen, Cornelis Johannes Maria Melief, Miranda Bernardina Johanna Molenaar, Elvin Irsan Kooi, Richard Johannes van Duin, Thomas Morsch